Physician profile
Mark A Jones
NPI 1588652564
$1,320.42
in general payments reported to CMS, 2019-2025
10 companies · $340 in 2025
The $340 reported for 2025 was more than what 95% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $79.88 · 2023: $176 · 2024: $555 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $879.09 | 2023-2025 | Inspire |
| Alexion Pharmaceuticals, INC. | $116.88 | 2021 | |
| Leo Pharma INC. | $77.32 | 2021-2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $72.15 | 2022-2024 | Sotyktu |
| Vanda Pharmaceuticals INC. | $45.56 | 2023 | Hetlioz |
| Sandoz INC. | $34.73 | 2023 | Hyrimoz |
| Smith+Nephew, INC. | $28.85 | 2024 | Intellio Link Werewolf, Na, N/A |
| Pacira Pharmaceuticals Incorporated | $27.34 | 2022 | |
| Atricure, INC. | $22.40 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.